DNA-PKcs抑制剂香兰素对宫颈癌患者细胞放化疗增敏效果探讨

详细信息    查看全文 | 推荐本文 |

英文篇名：Chemo-and radio-sensitization effects of DNA-PKcs inhibitor vanillin on human cervical cancer cells 作者：杨利 英文作者：YANG Li;Clinical Oncology Center,University of Hong Kong-Shenzhen Hospital; 关键词：DNA-PKcs抑制剂 ; 香兰素 ; 宫颈肿瘤 ; 顺铂 ; 放化疗增敏 英文关键词：DNA-PKcs inhibitor;;Vanillin;;Cervical neoplasms;;Cisplatin;;Chemo-and radio-sensitization 中文刊名：ZGZK 英文刊名：Chinese Journal of Clinical Oncology and Rehabilitation 机构：香港大学深圳医院临床肿瘤中心; 出版日期：2019-06-20 出版单位：中国肿瘤临床与康复 年：2019 期：v.26 语种：中文; 页：ZGZK201906004 页数：3 CN：06 ISSN：11-3494/R 分类号：15-17

摘要

目的探讨DNA依赖蛋白激酶催化亚单位(DNA-PKcs)抑制剂香兰素作用下宫颈癌Hela细胞对顺铂或电离辐射的敏感性,研究DNA-PKcs抑制剂对宫颈癌的放化疗增敏作用。方法采用四氮唑蓝还原法(MTT)检测香兰素联合顺铂对Hela细胞的增殖抑制作用;采用克隆形成试验(平板法)检测香兰素联合电离辐射对Hela细胞的增殖抑制作用。结果香兰素明显增加顺铂对Hela细胞的生长抑制作用,并呈一定剂量依赖性;香兰素也明显增加Hela细胞对电离辐射的敏感性,放射增敏比(SERDq)=1. 57。结论 DNA-PKcs抑制剂香兰素可能对顺铂治疗宫颈癌有增敏作用,也可能对宫颈癌放射治疗有增敏作用。
        Objective To observe the sensitivity of cervical cancer cell Hela to cisplatin or ionizing radiation under the action of DNA-dependent protein kinase catalytic subunit(DNA-PKcs) inhibitor vanillin,aiming to investigate the chemo-and radio-sensitization effects of DNA-PKcs inhibitor on cervical cancer cells. Methods The proliferation inhibition effect of vanillin combined with cisplatin on Hela cells was detected by tetrazolium blue reduction method(MTT). The proliferation inhibition effect of vanillin combined with ionizing radiation on Hela cells was investigated by colony formation assay(plate method). Results Vanillin significantly increased the growth inhibitory effect of cisplatin on Hela cells in a dose-dependent manner; vanillin also significantly increased the sensitivity of Hela cells to ionizing radiation with a sensitization ratio(SERDq) of 1. 57. Conclusion DNA-PKcs inhibitor vanillin may have chemo-and radio-sensitization effects in the treatment of cervical cancer.

引文

[1]Kowalczyk P,Jaworek J,Kot M,et al.Inflammation increases oxidative DNA damage repair and stimulates preneoplastic changes in colons of newborn rats[J].J Physiol Pharmacol,2016,67:277-286.
    [2]Al-Maghrebi M,Renno WM.Genistein alleviates testicular ischemia and reperfusion injury-induced spermatogenic damage and oxidative stress by suppressing abnormal testicular matrix metalloproteinase system via the Notch 2/Jagged 1/Hes-1 and caspase-8 pathways[J].J Physiol Pharmacol,2016,67:129-137.
    [3]Riddell IA.Cisplatin and oxaliplatin:our current understanding of their actions[J].Met Ions Life Sci,2018,18.
    [4]Monson KL,Ali S,Brandhagen MD,et al.Potential effects of ionizing radiation on the evidentiary value of DNA,latent fingerprints,hair,and fibers:a comprehensive review and new results[J].Forensic Sci Int,2018,284:204-218.
    [5]Giglia-Mari G,Zotter A,Vermeulen W.DNA damage response[J].Cold Spring Harb Perspect Biol,2011,3:297-303.
    [6]Shibata A.Regulation of repair pathway choice at two-ended DNA double-strand breaks[J].Mutat Res,2017,803-805:51-55.
    [7]Davis AJ,Chen BP,Chen DJ.DNA-PK:a dynamic enzyme in a versatile DSB repair pathway[J].DNA Repair(Amst),2014,17:21-29.
    [8]Davidson D,Amrein L,Panasci L,et al.Small molecules,inhibitors of DNA-PK,targeting DNA repair,and beyond[J].Front Pharmacol,2013,4:5.
    [9]Harnor SJ,Brennan A,Cano C.Targeting DNA-dependent protein kinase for cancer therapy[J].ChemMedChem,2017,12:895-900.
    [10]Clapham KM,Bardos J,Finlay MR,et al.DNA-dependent protein kinase(DNA-PK)inhibitors:structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain[J].Bioorg Med Chem Lett,2011,21:966-970.
    [11]Durant S,Karran P.Vanillins--a novel family of DNA-PK inhibitors[J].Nucleic Acids Res,2003,31:5501-5512.
    [12]Rose PG,Bundy BN,Watkins EB,et al.Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer[J].N Engl J Med,1999,340:1144-1153.
    [13]Convery E,Shin EK,Ding Q,et al.Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase(DNA-PKcs)[J].Proc Natl Acad Sci USA,2005,102:1345-1350.